Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Apr 10, 2026, 9:30 AM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 18.74 million as of April 10, 2026. Its market cap has decreased by -37.82% in one year.
Market Cap
18.74M
Enterprise Value
21.02M
Revenue
175.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 18.74M, an increase of 174.54%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 18.74M | -20.46% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cannabix Technologies | 89.49M |
| Theralase Technologies | 68.65M |
| Perimeter Medical Imaging AI | 43.54M |
| Conavi Medical | 40.88M |
| Cheelcare | 32.61M |
| Aurora Spine | 21.30M |
| MedX Health | 19.68M |
| VVT Med | 16.73M |